Neurontin Solution
Product Images NDC 58151-290

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Neurontin (NDC 58151-290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (Image 01)

Line graph depicting mean pain scores over an 8-week period comparing placebo and gabapentin 3600 mg/day. The x-axis represents weeks, including a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis represents mean pain scores, showing a decrease in pain with gabapentin over time compared to placebo.*

FDA Label Image

Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (Image 02)

Line graph depicting mean pain score over 7 weeks comparing placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents time in weeks, including a 3-week dose titration period and 4-week fixed dose period, while the y-axis measures mean pain score from 0 to 10. Gabapentin groups show a greater pain score reduction compared to placebo over time.*

FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Image 03)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares response rates between placebo (PBO) and gabapentin (GBP) at different dosages (3600 mg in Study 1, 1800 mg and 2400 mg in Study 2). The chart shows higher responder rates for gabapentin groups, with statistical significance indicated (** p < 0.01, *** p < 0.001). The Y-axis represents the percentage of responders from 0% to 100%.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Neurontin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 04)

A scatter plot showing the percentage difference on the y-axis versus daily gabapentin dose in milligrams on the x-axis. The graph compares results from three studies labeled a, b, and c, with data points at doses approximately 600 mg, 900 mg, 1200 mg, and 1800 mg. Each study is represented with different markers: black square for study a, gray square for study b, and white square for study c.*

FDA Label Image

Neurontin Capsules 100 mg Bottle Label (Image 05)

Label for Neurontin (gabapentin) 100 mg capsules by Viatris Specialty LLC. The label states storage instructions at 25°C with allowed excursions, dispensing guidance with medication guide, dosage unit information of 100 mg gabapentin per capsule, and package contains 100 capsules. The label includes a barcode and prescription-only status.*

FDA Label Image

Neurontin Capsules 300 mg Bottle Label (Image 06)

Neurontin 300 mg (gabapentin) capsules label from Viatris Specialty LLC. The label includes storage instructions, dosage and use notes, and indicates the package contains 100 capsules for oral use. The label also features a barcode and states the product is prescription only (Rx only).*

FDA Label Image

Neurontin Capsules 400 mg Bottle Label (Image 07)

Neurontin (gabapentin) capsules 400 mg label for oral use by Viatris Specialty LLC. The label specifies 100 capsules per container with prescription-only status. Storage instructions include maintaining 25°C (77°F) with permitted excursions between 15°C to 30°C (59°F to 86°F) and dispensing in child-resistant containers. Dosage and use direct to package insert for full information.*

FDA Label Image

Neurontin Tablets 600 mg Bottle Label (Image 08)

Neurontin (gabapentin) tablets 600 mg label for a package containing 100 tablets. The label includes storage instructions and states the product is prescription only. It is marked with the manufacturer Viatris Specialty LLC.*

FDA Label Image

Neurontin Tablets 800 mg Bottle Label (Image 09)

Neurontin 800 mg tablets label showing the brand name, generic name gabapentin, dosage strength (800 mg), quantity (100 tablets), and prescription status (Rx only). Storage instructions indicate controlled room temperature between 15°C to 30°C. The label advises dispensing in tight, child-resistant containers and refers to package insert for dosing information. Labeler is Viatris Specialty LLC.*

FDA Label Image

Neurontin Oral Solution 250 mg Per 5 mL Carton Label (Image 10)

Neurontin (gabapentin) oral solution packaging label showing a strength of 250 mg per 5 mL in a 470 mL container. The label displays the proprietary and generic names, dosage form, strength, and volume. The labeler is Viatris Specialty LLC, with instructions to always dispense with a medication guide. Storage instructions and barcode are also visible.*

FDA Label Image

Equation (Neurontin 01)

This image shows a formula for calculating creatinine clearance (CLCr) based on age, weight, serum creatinine levels, and a correction factor for female patients. It is a mathematical expression used for renal function assessment.*

FDA Label Image

Chemical Structure (Neurontin 02)

Chemical structure diagram showing a cyclohexane ring bonded to an amino methyl group (CH2NH2) and a carboxymethyl group (CH2CO2H), representing the active ingredient gabapentin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.